The exponential leap in generative AI is already transforming many industries: optimizing workflows, helping human teams focus on value-added tasks, and accelerating time to market. The life sciences industry, burdened by long R&D cycles and labor-intensive clinical, manufacturing, and compliancy regimens, is beginning to take notice.
The industry is under tremendous pressure to accelerate drug development at an optimal cost, automate time- and labor-intensive tasks, and accelerate delivery. The industry is also experiencing an explosion of digital data being created across the value chain.
This increase in digital data—in combination with a lack of skilled resources to ingest and process the data in a compliant manner—is forcing life sciences organizations to explore AI, machine learning, and now generative AI technologies. Read the full blog to learn more.